BLUE vs. NCSM

Last updated Apr 2, 2026

Compare and contrast key facts about bluebird bio, Inc. (BLUE) and NCS Multistage Holdings, Inc. (NCSM).

Performance

BLUE vs. NCSM - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in bluebird bio, Inc. (BLUE) and NCS Multistage Holdings, Inc. (NCSM). The values are adjusted to include any dividend payments, if applicable.

BLUE vs. NCSM - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
BLUE bluebird bio, Inc.	0.00%	-40.41%	-69.78%	-80.06%	-30.73%	-64.35%	-50.69%	-11.54%	-44.30%	100.22%
NCSM NCS Multistage Holdings, Inc.	52.47%	52.12%	45.43%	-28.60%	-13.76%	28.79%	-46.40%	-58.74%	-65.47%	-26.34%

Fundamentals

Total Revenue (TTM) BLUE : $103.95M NCSM : $183.63M
Gross Profit (TTM) BLUE : $28.19M NCSM : $75.43M
EBITDA (TTM) BLUE : -$115.82M NCSM : $19.22M

Returns By Period

BLUE

• 1D: —
• 1M: —
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

NCSM

• 1D: -2.64%
• 1M: 47.10%
• YTD: 52.47%
• 6M: 18.06%
• 1Y: 66.51%
• 3Y*: 36.45%
• 5Y*: 18.14%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

BLUE vs. NCSM — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

NCSM

NCSM Risk / Return Rank: 72
NCSM Sharpe Ratio Rank: 73
NCSM Sortino Ratio Rank: 72
NCSM Omega Ratio Rank: 70
NCSM Calmar Ratio Rank: 77
NCSM Martin Ratio Rank: 69

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

BLUE vs. NCSM - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for bluebird bio, Inc. (BLUE) and NCS Multistage Holdings, Inc. (NCSM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

Sharpe Ratios by Period

	BLUE	NCSM	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	—	0.98	—
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	—	0.30	—
Sharpe Ratio (All Time) Calculated using the full available price history	—	-0.25	—

Correlation

The correlation between BLUE and NCSM is 0.08, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

BLUE vs. NCSM - Dividend Comparison

Neither BLUE nor NCSM has paid dividends to shareholders.

Tickers have no history of dividend payments

Drawdowns

Drawdown Indicators

	BLUE	NCSM	Difference
Max Drawdown Largest peak-to-trough decline	—	-98.58%	—
Max Drawdown (1Y) Largest decline over 1 year	—	-33.80%	—
Max Drawdown (5Y) Largest decline over 5 years	—	-78.56%	—
Current Drawdown Current decline from peak	—	-88.87%	—
Average Drawdown Average peak-to-trough decline	—	-83.10%	—
Ulcer Index Depth and duration of drawdowns from previous peaks	—	21.00%	—

Volatility

Volatility by Period

	BLUE	NCSM	Difference
Volatility (1M) Calculated over the trailing 1-month period	—	31.33%	—
Volatility (6M) Calculated over the trailing 6-month period	—	48.11%	—
Volatility (1Y) Calculated over the trailing 1-year period	—	68.47%	—
Volatility (5Y) Calculated over the trailing 5-year period, annualized	—	60.47%	—
Volatility (10Y) Calculated over the trailing 10-year period, annualized	—	77.28%	—

Financials